Nanjing Medlander Medical Technology Co. Ltd. A Asset Resilience Ratio

Latest as of June 2025: 34.29%

Nanjing Medlander Medical Technology Co. Ltd. A asset resilience ratio. Nanjing Medlander Medical Technology Co. Ltd. A (688273) has an Asset Resilience Ratio of 34.29% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688273 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥522.25 Million

≈ $76.42 Million USD Cash + Short-term Investments

Total Assets

CN¥1.52 Billion

≈ $222.85 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Nanjing Medlander Medical Technology Co. Ltd. A (2022–2024)

Asset resilience ratio of Nanjing Medlander Medical Technology Co. Ltd. A from 2022 to 2024. This chart shows how Nanjing Medlander Medical Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688273 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Nanjing Medlander Medical Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688273 asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥522.25 Million	34.29%
Total Liquid Assets	CN¥522.25 Million	34.29%

Asset Resilience Insights

Very High Liquidity: Nanjing Medlander Medical Technology Co. Ltd. A maintains exceptional liquid asset reserves at 34.29% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Nanjing Medlander Medical Technology Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Nanjing Medlander Medical Technology Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Modular Medical Inc NASDAQ:MODD	Medical Devices	16.40%
Edwards Lifesciences Corp NYSE:EW	Medical Devices	9.71%
GN Store Nord CO:GN	Medical Devices	-4.56%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	Medical Devices	2.82%
Ningbo David Medical Device Co Ltd SHE:300314	Medical Devices	5.11%

Nanjing Medlander Medical Technology Co. Ltd. A Asset Resilience Ratio by Year (2022–2024)

Nanjing Medlander Medical Technology Co. Ltd. A asset resilience ratio by year from 2022 to 2024. The table below shows the annual Asset Resilience Ratio data for Nanjing Medlander Medical Technology Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	28.02%	CN¥433.42 Million ≈ $63.42 Million	CN¥1.55 Billion ≈ $226.32 Million	+21.14pp
2023-12-31	6.89%	CN¥105.65 Million ≈ $15.46 Million	CN¥1.53 Billion ≈ $224.46 Million	+4.24pp
2022-12-31	2.65%	CN¥40.00 Million ≈ $5.85 Million	CN¥1.51 Billion ≈ $221.24 Million	--

pp = percentage points

About Nanjing Medlander Medical Technology Co. Ltd. A

SHG:688273 China Medical Devices

Market Cap

$381.19 Million

CN¥2.60 Billion CNY

Market Cap Rank

#13634 Global

#4064 in China

Share Price

CN¥26.05

Change (1 day)

+0.35%

52-Week Range

CN¥25.96 - CN¥61.22

All Time High

CN¥61.22